Testimony: Recommendations on prescription drug prices program
September 12, 2024
Key Takeaways The Prescription Drug Price Disclosure Program succeeds in amassing prescription drug prices in an easily accessible format and has the potential to leverage existing federal filings to improve price transparency information. Compliance rates with the qualitative requirements of the statute are poor. Clarity regarding the two reports and the data required of each…